Externally Validated Machine Learning Models for 30-/90-/180-Day Unplanned Readmission After Head and Neck Cancer Hospitalizations in the United States Between January and June 2025, diagnostic ...
The prevalence of objectively measurable disease in phase III trials of metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results